Trajectory of Cognitive Decline Before and After Stroke in 14 Population Cohorts.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Oct 2024
Historique:
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Poststroke cognitive impairment is common, but the cognitive trajectory following a first stroke, relative to prestroke cognitive function, remains unclear. To map the trajectory of cognitive function before any stroke and after stroke in global cognition and in 4 cognitive domains, as well as to compare the cognitive trajectory prestroke in stroke survivors with the trajectory of individuals without incident stroke over follow-up. The study used harmonized and pooled data from 14 population-based cohort studies included in the Cohort Studies of Memory in an International Consortium collaboration. These studies were conducted from 1993 to 2019 across 11 countries among community-dwelling older adults without a history of stroke or dementia. For this study, linear mixed-effects models were used to estimate trajectories of cognitive function poststroke relative to a stroke-free cognitive trajectory. The full model adjusted for demographic and vascular risk factors. Data were analyzed from July 2022 to March 2024. Incident stroke. The primary outcome was global cognition, defined as the standardized average of 4 cognitive domains (language, memory, processing speed, and executive function). Cognitive domain scores were formed by selecting the most commonly administered test within each domain and standardizing the scores. The study included 20 860 participants (12 261 [58.8%] female) with a mean (SD) age of 72.9 (8.0) years and follow-up of 7.51 (4.2) years. Incident stroke was associated with a substantial acute decline in global cognition (-0.25 SD; 95% CI, -0.33 to -0.17 SD), the Mini-Mental State Examination, and all cognitive domains (ranging from -0.17 SD to -0.22 SD), as well as accelerated decline in global cognition (-0.038 SD per year; 95% CI, -0.057 to -0.019 SD per year) and all domains except memory (ranging from -0.020 to -0.055 SD per year), relative to a stroke-free cognitive trajectory. There was no significant difference in prestroke slope in stroke survivors compared with the rate of decline in individuals without stroke in all cognitive measures. The mean rate of decline without a previous stroke was -0.049 SD per year (95% CI, -0.051 to -0.047 SD) in global cognition. In this cohort study using pooled data from 14 cohorts, incident stroke was associated with acute and accelerated long-term cognitive decline in older stroke survivors.

Identifiants

pubmed: 39356504
pii: 2824331
doi: 10.1001/jamanetworkopen.2024.37133
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2437133

Auteurs

Jessica W Lo (JW)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

John D Crawford (JD)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

Darren M Lipnicki (DM)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

Richard B Lipton (RB)

Saul B. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York.

Mindy J Katz (MJ)

Saul B. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York.

Pierre-Marie Preux (PM)

Inserm U1094, IRD UMR270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.

Maëlenn Guerchet (M)

Inserm U1094, IRD UMR270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France.
Laboratory of Chronic and Neurological Diseases Epidemiology, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.

Eleonora d'Orsi (E)

Federal University of Santa Catarina, Trindade University Campus, Florianópolis, Santa Catarina, Brazil.

Anna Quialheiro (A)

IA&Saúde-The Artificial Intelligence and Health Research Unit, Polytechnic University of Health, CESPU, Portugal.

Cassiano Ricardo Rech (CR)

Department of Physical Education, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.

Karen Ritchie (K)

Inserm U1061: Neuropsychiatrie Hôpital La Colombière, BP34493, Montpellier, France.

Ingmar Skoog (I)

Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Region Västra Götaland, Sahlgrenska University Hospital, Psychiatry, Cognition and Old Age Psychiatry Clinic, Gothenburg, Sweden.

Jenna Najar (J)

Section of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Psychotic Disorders, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
Section Genomics of Neurdegenerative Diseases and Aging, Department of Human Genetics Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.

Therese Rydberg Sterner (TR)

Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
Neuropsychiatric Epidemiology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, Centre for Ageing and Health, University of Gothenburg, Gothenburg, Sweden.

Elena Rolandi (E)

Golgi Cenci Foundation, Abbiategrasso, Italy.
Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy.

Annalisa Davin (A)

Golgi Cenci Foundation, Abbiategrasso, Italy.

Michele Rossi (M)

Golgi Cenci Foundation, Abbiategrasso, Italy.

Steffi G Riedel-Heller (SG)

Faculty of Medicine, Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.

Alexander Pabst (A)

Faculty of Medicine, Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.

Susanne Röhr (S)

Faculty of Medicine, Institute of Social Medicine, Occupational Health and Public Health, University of Leipzig, Leipzig, Germany.
School of Psychology, Massey University, Albany Campus, Auckland, Aotearoa, New Zealand.
Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Mary Ganguli (M)

Departments of Psychiatry, Neurology, and Epidemiology, School of Medicine and School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania.

Erin Jacobsen (E)

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Beth E Snitz (BE)

Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Kaarin J Anstey (KJ)

Ageing Futures Institute, University of New South Wales, Sydney, Australia.
Neuroscience Research Australia, Sydney, Australia.
School of Psychology, University of New South Wales, Sydney, Australia.

Allison E Aiello (AE)

Department of Epidemiology and Robert N. Butler Columbia Aging Center, Mailman School of Public Health, Columbia University, New York, New York.

Henry Brodaty (H)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

Nicole A Kochan (NA)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

Yen-Ching Chen (YC)

Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Master Program of Statistics, National Taiwan University, Taipei, Taiwan.

Jen-Hau Chen (JH)

Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan.
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Pascual Sanchez-Juan (P)

Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, 28031, Madrid, Spain.

Teodoro Del Ser (T)

Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, 28031, Madrid, Spain.

Meritxell Valentí (M)

Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, 28031, Madrid, Spain.

Antonio Lobo (A)

Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.

Concepción De-la-Cámara (C)

Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.

Elena Lobo (E)

Department of Medicine and Psychiatry, Universidad de Zaragoza, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain.
Department of Preventive Medicine and Public Health, Universidad de Zaragoza, Zaragoza, Spain.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH